查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1950355

寵物益生菌市場依動物類型、形態、來源和通路分類，全球預測（2026-2032年）

Probiotics for Pets Market by Animal Type, Form, Source, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，寵物益生菌市場價值將達到 6.2538 億美元，到 2026 年將成長至 7.1395 億美元，到 2032 年將達到 16.5064 億美元，複合年成長率為 14.87%。

關鍵市場統計數據
基準年 2025 6.2538億美元
預計年份：2026年 7.1395億美元
預測年份 2032 16.5064億美元
複合年成長率 (%) 14.87%

簡要介紹影響寵物益生菌的當前促進因素、科學檢驗和消費者趨勢的背景和基本框架

寵物益生菌市場已從小眾保健品發展成為營養、獸醫學和寵物飼主生活方式選擇交匯處的策略性類別。本導言為希望了解影響現代決策因素（包括需求促進因素、產品創新和分銷動態）的相關人員提供了必要的背景資訊。它清晰地區分了貓和狗的不同考量因素，重點闡述了科學檢驗、監管關注和寵物護理人性化趨勢之間的相互作用。

科學檢驗、消費者人性化以及全通路零售的演變如何重新定義該領域的競爭優勢

寵物益生菌市場正經歷著變革性的轉變，多種因素的匯聚正在重塑競爭格局和投資重點。首先，隨著微生物組科學日益成熟，能夠提供可操作的菌株層面見解，配方師們正從通用菌種轉向以實證醫學為基礎、針對特定生理效應的益生菌。這種轉變促使研究合作和臨床檢驗成為重要的差異化因素，並鼓勵製造商投資於能夠維持多種劑型活性的穩定性平台。

2025年關稅調整對寵物益生菌生產商採購韌性、成本控制和供應鏈透明度的策略影響

2025年關稅政策的變化給寵物益生菌價值鏈上的相關人員帶來了新的挑戰，包括供應鏈規劃、採購和定價策略。某些原料和半成品的關稅提高，加劇了依賴進口菌種、包埋技術和特殊穩定劑的配方對成本的敏感度。這種環境迫使採購團隊重新評估供應商多樣性、庫存緩衝和近岸外包機會，以在不影響產品性能的前提下維持利潤率。

透過深度細分洞察，將菌株選擇、物種特定需求、配方和分銷管道轉化為可執行的商業策略。

了解市場區隔如何影響產品策略和商業化，對於設計能夠引起終端用戶和通路夥伴共鳴的提案至關重要。在考慮原料來源時，市場將產品分為細菌基和酵母基兩類。在細菌基解決方案中，雙歧桿菌和乳酸桿菌菌株因其已確立的安全性以及對腸道健康的顯著益處，在開發平臺中主導地位。而酵母基配方則通常採用釀酒酵母，因為其穩定性高且具有獨特的功能特性。

美洲、歐洲、中東和非洲以及亞太地區的趨勢如何重塑產品優先事項、分銷策略和監管重點

區域趨勢對全球產品開發重點、通路策略和監管計畫有顯著影響。在美洲，優質化和強大的直銷管道往往主導著消費者的接受趨勢，而與獸醫的合作則有助於建立信任。在該地區運營的品牌通常注重潔淨標示和訂閱模式，以確保持續的收入並最大化客戶終身價值。

競爭格局因素凸顯了科學合作、生產管理和全通路分銷策略的策略價值。

寵物益生菌領域的競爭格局由科學知識、通路關係和供應鏈管理三者共同決定。主要企業正加大對菌株層面研究、臨床研究合作以及配方技術的投入，以延長產品保存期限並提升其功效。與獸醫組織和臨床研究人員的合作能夠增強產品的可信度，並為臨床應用和專家推薦鋪平道路。

領導者應採取具體策略，整合研發檢驗、供應鏈韌性和全通路商業化，以實現永續優勢。

產業領導者應採取整合研發、監管事務和商業性執行的策略，以確保長期成長，同時降低短期營運風險。應投資進行可靠的菌株檢驗和穩定性研究，以直接支持獸醫和知情寵物飼主最為關注的聲明。此外，還應透過臨床合作和同行評審研究來補充這些投資，將生物學合理性轉化為可供專家參考的可操作證據。

採用透明的多學科調查方法，結合專家訪談、系統性二手研究和資料三角驗證，以產生可複製的策略性見解。

本執行摘要的研究方法結合了定性專家意見、系統性的二手研究和三角驗證，以確保提供可靠的實踐見解。主要定性資料是透過對獸醫學、製劑科學、零售採購和供應鏈管理領域的專家進行結構化訪談收集的，旨在了解從業人員的觀點和新出現的營運挑戰。這些訪談為觀察到的商業性和監管趨勢提供了背景基礎。

簡明扼要地總結了品類轉折點和策略重點，指導企業實現檢驗的創新、韌性和永續差異化。

總之，寵物益生菌產業正處於一個轉捩點。科學的成熟、消費者期望的不斷變化以及商業結構的轉變交織在一起，既帶來了機遇，也帶來了挑戰。那些優先考慮菌株篩選、建立穩健供應鏈和最佳化通路策略的公司，更有能力將技術優勢轉化為商業性成功。監管檢驗和關稅政策的變化進一步凸顯了透明的原產地管理和靈活的籌資策略的重要性。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 依動物種類分類的寵物益生菌市場

  • 貓
  • 狗

9. 寵物益生菌市場（依形式分類）

  • 膠囊
    • 硬膠囊
    • 軟膠囊
  • 液體
    • 濃縮型
    • 即飲型
  • 粉末
    • 散裝粉末
    • 小袋
  • 藥片
    • 咀嚼片
    • 普通片劑

第10章：按食材分類的寵物益生菌市場

  • 細菌
    • 雙歧桿菌
    • 乳酸菌
  • 酵母菌

第11章：寵物益生菌市場（依通路分類）

  • 量販店
    • 大型超級市場
    • 超級市場
  • 線上零售
    • 電子商務平台
    • 製造商官方網站
  • 寵物專賣店
    • 連鎖店
    • 獨立商店
  • 藥局
    • 網路藥房
    • 零售藥房
  • 獸醫診所
    • 獸醫診所
    • 私人診所

第12章：寵物益生菌市場區域分析

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章：寵物益生菌市場（依類別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章：各國寵物益生菌市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

15. 美國寵物益生菌市場

16. 中國：寵物益生菌市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Animal Essentials
  • Ark Naturals, Inc.
  • Bayer Animal Health
  • Blue Buffalo Company, Ltd.
  • Chr. Hansen A/S
  • Diamond Pet Foods, Inc.
  • DuPont de Nemours, Inc.
  • Elanco Animal Health Incorporated
  • FoodScience Corporation
  • Hill's Pet Nutrition, Inc.
  • Honest Paws, Inc.
  • Koninklijke DSM NV
  • Lallemand Inc.
  • Mars Petcare, Inc.
  • Nature's Variety, Inc.
  • Nestle Purina PetCare Company
  • Novozymes A/S
  • NOW Foods, Inc.
  • Nutramax Laboratories, Inc.
  • PetAg, Inc.
  • PetHonesty, LLC
  • Probiotics International Ltd.
  • Radio Systems Corporation
  • RedDog
  • Swanson Health Products, Inc.
  • Swedencare AB
  • Vetoquinol SA
  • VetriScience Laboratories, Inc.
  • Virbac SA
  • Zesty Paws, LLC
  • Zoetis Inc.
Product Code: MRR-4F7A6D4FD810

The Probiotics for Pets Market was valued at USD 625.38 million in 2025 and is projected to grow to USD 713.95 million in 2026, with a CAGR of 14.87%, reaching USD 1,650.64 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 625.38 million
Estimated Year [2026] USD 713.95 million
Forecast Year [2032] USD 1,650.64 million
CAGR (%) 14.87%

Concise context and foundational framing of current drivers, scientific validation, and consumer dynamics shaping probiotics for companion animals

The landscape of probiotics for companion animals has matured from a niche wellness supplement into a strategic category intersecting nutrition, veterinary care, and pet-owner lifestyle choices. This introduction lays out the essential context for stakeholders seeking clarity on demand drivers, product innovation, and distribution dynamics that shape contemporary decision-making. It emphasizes the interplay between scientific validation, regulatory attention, and humanization trends in pet care while underscoring the distinct considerations that separate formulations intended for cats and dogs.

Emerging evidence linking microbiome modulation to digestive health, immune resilience, and behavioral outcomes has catalyzed interest across breeders, veterinarians, and pet food manufacturers. Simultaneously, advances in strain characterization and stability technologies have enabled a broader set of delivery formats, opening opportunities for integration into daily feeding routines and clinical regimens alike. This introduction stresses the importance of rigorous strain selection, formulation stability, and palatability as core determinants of clinical utility and consumer acceptance.

Finally, the section frames the remainder of the executive summary by highlighting how innovation in product form, targeted species applications, and evolving retail structures are collectively reshaping competitive advantage. Readers should then be prepared to consider the strategic implications and tactical responses explored across the subsequent sections of this report.

How scientific validation, consumer humanization, and omnichannel retail evolution are collectively redefining competitive advantage in the category

The probiotics for pets category is undergoing transformative shifts driven by several converging forces that rewrite competitive expectations and investment priorities. First, the maturation of microbiome science into actionable strain-level insights has encouraged formulators to move beyond generic cultures and toward evidence-driven probiotics targeted to specific physiological outcomes. This shift elevates research partnerships and clinical validation as differentiators, and it prompts manufacturers to invest in stability platforms that preserve viability across diverse formats.

Second, consumer demand is increasingly shaped by the humanization of pets; owners expect products that mirror the quality and transparency they seek in human supplements. As a result, claims substantiation, clean-label positioning, and traceability now carry substantial premium potential. This trend also amplifies the role of veterinary endorsement and clinical pathways as trust signals, which, in turn, influences adoption among more discerning pet owners.

Third, digitization of retail and data-driven personalization are enabling new customer journeys. Direct-to-consumer channels and subscription models allow brands to collect longitudinal data on product use and outcomes, informing iterative product improvements and bespoke formulations. At the same time, omnichannel strategies that harmonize mass retail visibility with specialized veterinary distribution are becoming essential for scale.

Collectively, these shifts create an environment where strategic differentiation arises from the integration of scientific credibility, consumer-facing transparency, and omnichannel execution. Companies that align R&D, regulatory, and commercial capabilities around these vectors can convert technical advances into sustained customer loyalty.

Strategic implications of 2025 tariff adjustments on sourcing resilience, cost management, and supply-chain transparency for pet probiotics manufacturers

Tariff policy changes in 2025 have introduced a new set of considerations for supply chain planning, sourcing, and pricing strategies for stakeholders in the probiotics for pets value chain. Increased duties on certain raw materials and intermediate goods have heightened the cost sensitivity of formulations that rely on imported cultures, encapsulation technologies, or specialized stabilizers. This environment compels procurement teams to reassess supplier diversity, inventory buffers, and nearshoring opportunities to preserve margin integrity without compromising product performance.

Moreover, tariff volatility accentuates the value of transparent supply-chain mapping. Firms that maintain rigorous provenance data and multifactorial cost models are better positioned to execute rapid SKU rationalization and to communicate pricing adjustments to retail partners and consumers with credibility. In parallel, manufacturers with in-house fermentation or encapsulation capabilities can reduce exposure to cross-border cost fluctuations, though such capital investments require careful assessment relative to scale economies and technological maturity.

Regulatory alignment and trade policy forecasting also play a greater role in commercial planning. Companies that engage proactively with customs and regulatory advisors can anticipate classification risks and implement compliance measures that minimize disruption. Finally, tariff-driven cost pressures may accelerate product innovation focused on ingredient efficiency, higher-potency formulations that reduce per-dose raw-material intensity, or alternative delivery matrices that circumvent the most affected inputs.

Taken together, the cumulative impact of 2025 tariff adjustments underscores the need for adaptive supply-chain strategies, transparent cost communication, and targeted R&D investments to sustain competitiveness across markets.

Deep segmentation insights translating strain selection, species-specific needs, dosage forms, and distribution channels into pragmatic commercial strategies

Understanding how the market segments inform product strategy and commercialization is essential for designing propositions that resonate with end users and channel partners. When considering source, the market differentiates between bacterial and yeast-based products. Within bacterial solutions, Bifidobacterium and Lactobacillus strains dominate development pipelines due to their established safety profiles and documented gut health associations, whereas yeast-based formulations typically leverage Saccharomyces for its stability and distinct functional properties.

Animal type segmentation requires distinct approaches for cats and dogs because physiological differences, feeding behaviors, and owner expectations drive formulation choices and communication strategies. Dog-targeted products often emphasize digestive support, joint and mobility adjuncts, and broader wellness claims, while cat-specific offerings must prioritize palatability, microbiome compositions that align with obligate carnivore physiology, and packaging formats that accommodate smaller dosing increments.

Form is another critical axis shaping product design and consumer convenience. Capsules are available as hard capsules and softgels, each offering different dissolution profiles and encapsulation advantages; liquids come as concentrates suitable for mixing and ready-to-drink presentations optimized for direct administration; powders are offered in bulk formats for formulators or as sachets for single-serve convenience; and tablets come in chewable formats for ease of administration or regular tablets for incorporation into feeding routines. Each form affects stability, dosing accuracy, and perceived value, and therefore should guide supply-chain choices, packaging innovation, and marketing narratives.

Distribution channel segmentation further nuances go-to-market plans. Mass retail includes hypermarkets and supermarkets that prioritize broad visibility and price competitiveness, while online retail spans e-commerce platforms and manufacturer websites that enable subscription and personalization models. Pet specialty stores, including chain stores and independent outlets, provide category expertise and experiential merchandising advantages. Pharmacies, both online and retail, offer clinical credibility and regulatory alignment, whereas veterinary clinics-ranging from animal hospitals to private clinics-serve as high-trust, treatment-oriented distribution points where clinical evidence and professional endorsement are paramount. Aligning product attributes and promotional tactics to these channel nuances enhances conversion and long-term retention.

How Americas, Europe Middle East & Africa, and Asia-Pacific regional dynamics are reshaping product priorities, channel strategies, and regulatory focus

Regional dynamics materially influence product development priorities, channel strategies, and regulatory planning across the globe. In the Americas, consumer adoption tends to be shaped by premiumization and strong direct-to-consumer channels, with veterinary partnerships enhancing credibility. Brands operating in this region often focus on clean-label narratives and subscription models that capture recurring revenue and enable customer lifetime value optimization.

In Europe, Middle East & Africa, regulatory scrutiny and label harmonization require careful product documentation and clinical substantiation. European consumers place high value on transparency and environmental considerations, prompting investments in sustainable packaging and supply-chain traceability. Meanwhile, markets across the Middle East and Africa can vary widely in distribution maturity, creating opportunities for targeted partnerships and regional manufacturing to bridge logistical gaps.

The Asia-Pacific region is characterized by heterogeneous consumer behaviors and rapid innovation adoption. In some markets, rising pet ownership and growing discretionary spend fuel demand for novel formats and premium propositions, while in others, price sensitivity necessitates efficient formulations and scalable manufacturing approaches. The region also presents significant opportunities for localized strain research and collaborative clinical studies that reflect regional breed profiles and feeding practices.

Across these regions, competitive advantage accrues to organizations that harmonize global standards with local customization, enabling consistent brand trust while addressing market-specific clinical, regulatory, and cultural requirements.

Competitive landscape drivers highlighting the strategic value of scientific partnerships, manufacturing control, and omnichannel commercialization tactics

Competitive dynamics in the probiotics for pets category are defined by a combination of scientific capability, channel relationships, and supply-chain control. Leading organizations invest in strain-level research, clinical collaborations, and formulation technologies that extend shelf life and support differentiated claims. Partnerships with veterinary institutions and clinical researchers enhance credibility and provide practical pathways to clinical adoption and professional endorsements.

Supply-chain integration and manufacturing flexibility are also decisive. Firms that can secure robust fermentation, encapsulation, and packaging capabilities reduce exposure to external shocks and improve margins. At the same time, strategic alliances with ingredient suppliers and contract manufacturers can accelerate time-to-market for specialized formats and enable rapid product iteration in response to emerging evidence.

Commercially, companies that execute omnichannel strategies-balancing mass retail penetration with targeted veterinary and specialty distribution plus direct digital engagement-achieve greater resilience and customer lifetime value. Marketing sophistication that combines transparent science communication with behaviorally informed digital touchpoints enhances conversion and retention. Finally, organizations that prioritize intellectual property around unique strain combinations, delivery matrices, and stabilization technology create durable differentiation while opening licensing or co-development pathways with large animal health and pet food firms.

Concrete strategic actions for leaders to align R&D validation, supply-chain resilience, and omnichannel commercialization to capture durable advantage

Industry leaders should adopt an integrated strategy that aligns R&D, regulatory, and commercial execution to capture long-term growth while mitigating near-term operational risks. Invest in robust strain validation and stability research that directly supports claims most valued by veterinarians and informed pet owners. Complement these investments with clinical collaborations and peer-reviewed studies that translate biological plausibility into actionable evidence for professional endorsement.

On supply-chain resilience, diversify sourcing across geographies and consider selective nearshoring for critical inputs vulnerable to tariff or logistics volatility. Simultaneously, evaluate opportunities to internalize high-value manufacturing steps such as encapsulation or starter-culture development where scale economics justify capital deployment. In pricing and channel strategy, adopt differentiated SKUs that reflect premium, clinical, and value tiers, and tailor channel-specific packaging and merchandising to enhance conversion across mass, specialty, pharmacy, and clinical outlets.

From a commercial perspective, develop omnichannel customer journeys that leverage subscription mechanics, post-purchase outcome tracking, and veterinarian-facing educational resources. Use consumer data ethically to refine segmentation and personalize communications, while maintaining strong privacy and compliance governance. Lastly, prioritize sustainability and traceability initiatives that respond to consumer preferences and reduce long-term operational risks, turning compliance into a marketable asset rather than a cost center.

Transparent multidisciplinary research methodology combining expert interviews, systematic secondary analysis, and data triangulation for replicable strategic insights

The research approach underpinning this executive summary combines qualitative expert input with systematic secondary analysis and triangulation to ensure robust, actionable insights. Primary qualitative inputs were gathered through structured interviews with subject-matter experts across veterinary medicine, formulation science, retail buying, and supply-chain management to capture practitioner perspectives and emerging operational challenges. These interviews provided contextual grounding for observed commercial and regulatory trends.

Secondary research synthesized publicly available scientific literature, regulatory guidance, and industry disclosures to map strain-level developments, packaging innovations, and channel behaviors. Findings were cross-validated through comparative analysis across regional regulatory frameworks and distribution models to identify transferable strategies and region-specific constraints. Data triangulation ensured that strategic observations were corroborated across multiple independent inputs.

Analytical techniques included thematic coding of qualitative inputs, cross-sectional mapping of distribution channels to product formats, and scenario analysis to explore the impact of tariff and supply-chain variability on commercial options. Quality control processes incorporated peer reviews and methodological documentation to support reproducibility and to allow stakeholders to assess the applicability of insights to their operational context.

Concise synthesis of category inflection points and strategic priorities that direct firms toward validated innovation, resilience, and sustained differentiation

In conclusion, the probiotics for pets category stands at an inflection point where scientific maturation, evolving consumer expectations, and shifting commercial architectures converge to create both opportunity and complexity. Firms that prioritize validated strain selection, resilient supply chains, and nuanced channel strategies are better positioned to translate technical capability into commercial success. The interplay of regulatory scrutiny and tariff dynamics further elevates the importance of transparent provenance and adaptive sourcing strategies.

Actionable alignment between research, manufacturing, and sales functions is essential to navigate these dynamics. By integrating rigorous validation with customer-centric packaging and omnichannel execution, companies can build trust with veterinarians and pet owners alike, securing durable differentiation. The path forward favors organizations that balance scientific discipline with commercial agility and operational resilience.

Stakeholders that adopt the recommendations outlined in this summary will be prepared to respond to near-term headwinds while investing in the innovations and partnerships that define long-term leadership in the category.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Probiotics for Pets Market, by Animal Type

  • 8.1. Cat
  • 8.2. Dog

9. Probiotics for Pets Market, by Form

  • 9.1. Capsule
    • 9.1.1. Hard Capsule
    • 9.1.2. Softgel
  • 9.2. Liquid
    • 9.2.1. Concentrates
    • 9.2.2. Ready To Drink
  • 9.3. Powder
    • 9.3.1. Bulk Powder
    • 9.3.2. Sachets
  • 9.4. Tablet
    • 9.4.1. Chewable Tablets
    • 9.4.2. Regular Tablets

10. Probiotics for Pets Market, by Source

  • 10.1. Bacteria
    • 10.1.1. Bifidobacterium
    • 10.1.2. Lactobacillus
  • 10.2. Yeast

11. Probiotics for Pets Market, by Distribution Channel

  • 11.1. Mass Retail
    • 11.1.1. Hypermarkets
    • 11.1.2. Supermarkets
  • 11.2. Online Retail
    • 11.2.1. E Commerce Platforms
    • 11.2.2. Manufacturer Website
  • 11.3. Pet Specialty Stores
    • 11.3.1. Chain Stores
    • 11.3.2. Independent Stores
  • 11.4. Pharmacies
    • 11.4.1. Online Pharmacies
    • 11.4.2. Retail Pharmacies
  • 11.5. Veterinary Clinics
    • 11.5.1. Animal Hospitals
    • 11.5.2. Private Clinics

12. Probiotics for Pets Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Probiotics for Pets Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Probiotics for Pets Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Probiotics for Pets Market

16. China Probiotics for Pets Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Animal Essentials
  • 17.6. Ark Naturals, Inc.
  • 17.7. Bayer Animal Health
  • 17.8. Blue Buffalo Company, Ltd.
  • 17.9. Chr. Hansen A/S
  • 17.10. Diamond Pet Foods, Inc.
  • 17.11. DuPont de Nemours, Inc.
  • 17.12. Elanco Animal Health Incorporated
  • 17.13. FoodScience Corporation
  • 17.14. Hill's Pet Nutrition, Inc.
  • 17.15. Honest Paws, Inc.
  • 17.16. Koninklijke DSM N.V.
  • 17.17. Lallemand Inc.
  • 17.18. Mars Petcare, Inc.
  • 17.19. Nature's Variety, Inc.
  • 17.20. Nestle Purina PetCare Company
  • 17.21. Novozymes A/S
  • 17.22. NOW Foods, Inc.
  • 17.23. Nutramax Laboratories, Inc.
  • 17.24. PetAg, Inc.
  • 17.25. PetHonesty, LLC
  • 17.26. Probiotics International Ltd.
  • 17.27. Radio Systems Corporation
  • 17.28. RedDog
  • 17.29. Swanson Health Products, Inc.
  • 17.30. Swedencare AB
  • 17.31. Vetoquinol S.A.
  • 17.32. VetriScience Laboratories, Inc.
  • 17.33. Virbac S.A.
  • 17.34. Zesty Paws, LLC
  • 17.35. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PROBIOTICS FOR PETS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PROBIOTICS FOR PETS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY FORM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY SOURCE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES PROBIOTICS FOR PETS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA PROBIOTICS FOR PETS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY CAT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY CAT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY CAT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY DOG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY DOG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY DOG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY CAPSULE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY CAPSULE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY CAPSULE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY HARD CAPSULE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY HARD CAPSULE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY HARD CAPSULE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY SOFTGEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY SOFTGEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY SOFTGEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY LIQUID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY LIQUID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY CONCENTRATES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY CONCENTRATES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY CONCENTRATES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY READY TO DRINK, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY READY TO DRINK, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY READY TO DRINK, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY POWDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY POWDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY BULK POWDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY BULK POWDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY BULK POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY SACHETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY SACHETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY SACHETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY TABLET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY TABLET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY TABLET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY CHEWABLE TABLETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY CHEWABLE TABLETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY CHEWABLE TABLETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY REGULAR TABLETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY REGULAR TABLETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY REGULAR TABLETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY BACTERIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY BACTERIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY BACTERIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY BACTERIA, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY BIFIDOBACTERIUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY BIFIDOBACTERIUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY BIFIDOBACTERIUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY LACTOBACILLUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY LACTOBACILLUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY LACTOBACILLUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY YEAST, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY YEAST, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY YEAST, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY MASS RETAIL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY MASS RETAIL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY MASS RETAIL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY MASS RETAIL, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY HYPERMARKETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY HYPERMARKETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY HYPERMARKETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY SUPERMARKETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY SUPERMARKETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY SUPERMARKETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY ONLINE RETAIL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY ONLINE RETAIL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY E COMMERCE PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY E COMMERCE PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY E COMMERCE PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY MANUFACTURER WEBSITE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY MANUFACTURER WEBSITE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY MANUFACTURER WEBSITE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY PET SPECIALTY STORES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY PET SPECIALTY STORES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY PET SPECIALTY STORES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY PET SPECIALTY STORES, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY CHAIN STORES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY CHAIN STORES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY CHAIN STORES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY INDEPENDENT STORES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY INDEPENDENT STORES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY INDEPENDENT STORES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY ONLINE PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY VETERINARY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY VETERINARY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY VETERINARY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY ANIMAL HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY ANIMAL HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY ANIMAL HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY PRIVATE CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY PRIVATE CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY PRIVATE CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. AMERICAS PROBIOTICS FOR PETS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 117. AMERICAS PROBIOTICS FOR PETS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. AMERICAS PROBIOTICS FOR PETS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 119. AMERICAS PROBIOTICS FOR PETS MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
  • TABLE 120. AMERICAS PROBIOTICS FOR PETS MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 121. AMERICAS PROBIOTICS FOR PETS MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 122. AMERICAS PROBIOTICS FOR PETS MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
  • TABLE 123. AMERICAS PROBIOTICS FOR PETS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 124. AMERICAS PROBIOTICS FOR PETS MARKET SIZE, BY BACTERIA, 2018-2032 (USD MILLION)
  • TABLE 125. AMERICAS PROBIOTICS FOR PETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 126. AMERICAS PROBIOTICS FOR PETS MARKET SIZE, BY MASS RETAIL, 2018-2032 (USD MILLION)
  • TABLE 127. AMERICAS PROBIOTICS FOR PETS MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 128. AMERICAS PROBIOTICS FOR PETS MARKET SIZE, BY PET SPECIALTY STORES, 2018-2032 (USD MILLION)
  • TABLE 129. AMERICAS PROBIOTICS FOR PETS MARKET SIZE, BY PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 130. AMERICAS PROBIOTICS FOR PETS MARKET SIZE, BY VETERINARY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA PROBIOTICS FOR PETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA PROBIOTICS FOR PETS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA PROBIOTICS FOR PETS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 134. NORTH AMERICA PROBIOTICS FOR PETS MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA PROBIOTICS FOR PETS MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 136. NORTH AMERICA PROBIOTICS FOR PETS MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 137. NORTH AMERICA PROBIOTICS FOR PETS MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
  • TABLE 138. NORTH AMERICA PROBIOTICS FOR PETS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA PROBIOTICS FOR PETS MARKET SIZE, BY BACTERIA, 2018-2032 (USD MILLION)
  • TABLE 140. NORTH AMERICA PROBIOTICS FOR PETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA PROBIOTICS FOR PETS MARKET SIZE, BY MASS RETAIL, 2018-2032 (USD MILLION)
  • TABLE 142. NORTH AMERICA PROBIOTICS FOR PETS MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 143. NORTH AMERICA PROBIOTICS FOR PETS MARKET SIZE, BY PET SPECIALTY STORES, 2018-2032 (USD MILLION)
  • TABLE 144. NORTH AMERICA PROBIOTICS FOR PETS MARKET SIZE, BY PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA PROBIOTICS FOR PETS MARKET SIZE, BY VETERINARY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 146. LATIN AMERICA PROBIOTICS FOR PETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. LATIN AMERICA PROBIOTICS FOR PETS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. LATIN AMERICA PROBIOTICS FOR PETS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 149. LATIN AMERICA PROBIOTICS FOR PETS MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
  • TABLE 150. LATIN AMERICA PROBIOTICS FOR PETS MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 151. LATIN AMERICA PROBIOTICS FOR PETS MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 152. LATIN AMERICA PROBIOTICS FOR PETS MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
  • TABLE 153. LATIN AMERICA PROBIOTICS FOR PETS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 154. LATIN AMERICA PROBIOTICS FOR PETS MARKET SIZE, BY BACTERIA, 2018-2032 (USD MILLION)
  • TABLE 155. LATIN AMERICA PROBIOTICS FOR PETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 156. LATIN AMERICA PROBIOTICS FOR PETS MARKET SIZE, BY MASS RETAIL, 2018-2032 (USD MILLION)
  • TABLE 157. LATIN AMERICA PROBIOTICS FOR PETS MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 158. LATIN AMERICA PROBIOTICS FOR PETS MARKET SIZE, BY PET SPECIALTY STORES, 2018-2032 (USD MILLION)
  • TABLE 159. LATIN AMERICA PROBIOTICS FOR PETS MARKET SIZE, BY PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 160. LATIN AMERICA PROBIOTICS FOR PETS MARKET SIZE, BY VETERINARY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA PROBIOTICS FOR PETS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA PROBIOTICS FOR PETS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA PROBIOTICS FOR PETS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE, MIDDLE EAST & AFRICA PROBIOTICS FOR PETS MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE, MIDDLE EAST & AFRICA PROBIOTICS FOR PETS MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE, MIDDLE EAST & AFRICA PROBIOTICS FOR PETS MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPE, MIDDLE EAST & AFRICA PROBIOTICS FOR PETS MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE, MIDDLE EAST & AFRICA PROBIOTICS FOR PETS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA PROBIOTICS FOR PETS MARKET SIZE, BY BACTERIA, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA PROBIOTICS FOR PETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA PROBIOTICS FOR PETS MARKET SIZE, BY MASS RETAIL, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA PROBIOTICS FOR PETS MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA PROBIOTICS FOR PETS MARKET SIZE, BY PET SPECIALTY STORES, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA PROBIOTICS FOR PETS MARKET SIZE, BY PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA PROBIOTICS FOR PETS MARKET SIZE, BY VETERINARY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPE PROBIOTICS FOR PETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE PROBIOTICS FOR PETS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE PROBIOTICS FOR PETS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE PROBIOTICS FOR PETS MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE PROBIOTICS FOR PETS MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE PROBIOTICS FOR PETS MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE PROBIOTICS FOR PETS MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE PROBIOTICS FOR PETS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE PROBIOTICS FOR PETS MARKET SIZE, BY BACTERIA, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE PROBIOTICS FOR PETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE PROBIOTICS FOR PETS MARKET SIZE, BY MASS RETAIL, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE PROBIOTICS FOR PETS MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE PROBIOTICS FOR PETS MARKET SIZE, BY PET SPECIALTY STORES, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE PROBIOTICS FOR PETS MARKET SIZE, BY PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE PROBIOTICS FOR PETS MARKET SIZE, BY VETERINARY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 191. MIDDLE EAST PROBIOTICS FOR PETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 192. MIDDLE EAST PROBIOTICS FOR PETS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. MIDDLE EAST PROBIOTICS FOR PETS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 194. MIDDLE EAST PROBIOTICS FOR PETS MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
  • TABLE 195. MIDDLE EAST PROBIOTICS FOR PETS MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 196. MIDDLE EAST PROBIOTICS FOR PETS MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 197. MIDDLE EAST PROBIOTICS FOR PETS MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
  • TABLE 198. MIDDLE EAST PROBIOTICS FOR PETS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 199. MIDDLE EAST PROBIOTICS FOR PETS MARKET SIZE, BY BACTERIA, 2018-2032 (USD MILLION)
  • TABLE 200. MIDDLE EAST PROBIOTICS FOR PETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 201. MIDDLE EAST PROBIOTICS FOR PETS MARKET SIZE, BY MASS RETAIL, 2018-2032 (USD MILLION)
  • TABLE 202. MIDDLE EAST PROBIOTICS FOR PETS MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST PROBIOTICS FOR PETS MARKET SIZE, BY PET SPECIALTY STORES, 2018-2032 (USD MILLION)
  • TABLE 204. MIDDLE EAST PROBIOTICS FOR PETS MARKET SIZE, BY PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 205. MIDDLE EAST PROBIOTICS FOR PETS MARKET SIZE, BY VETERINARY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 206. AFRICA PROBIOTICS FOR PETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 207. AFRICA PROBIOTICS FOR PETS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 208. AFRICA PROBIOTICS FOR PETS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 209. AFRICA PROBIOTICS FOR PETS MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
  • TABLE 210. AFRICA PROBIOTICS FOR PETS MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 211. AFRICA PROBIOTICS FOR PETS MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 212. AFRICA PROBIOTICS FOR PETS MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
  • TABLE 213. AFRICA PROBIOTICS FOR PETS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 214. AFRICA PROBIOTICS FOR PETS MARKET SIZE, BY BACTERIA, 2018-2032 (USD MILLION)
  • TABLE 215. AFRICA PROBIOTICS FOR PETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 216. AFRICA PROBIOTICS FOR PETS MARKET SIZE, BY MASS RETAIL, 2018-2032 (USD MILLION)
  • TABLE 217. AFRICA PROBIOTICS FOR PETS MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 218. AFRICA PROBIOTICS FOR PETS MARKET SIZE, BY PET SPECIALTY STORES, 2018-2032 (USD MILLION)
  • TABLE 219. AFRICA PROBIOTICS FOR PETS MARKET SIZE, BY PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 220. AFRICA PROBIOTICS FOR PETS MARKET SIZE, BY VETERINARY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 221. ASIA-PACIFIC PROBIOTICS FOR PETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 222. ASIA-PACIFIC PROBIOTICS FOR PETS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 223. ASIA-PACIFIC PROBIOTICS FOR PETS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 224. ASIA-PACIFIC PROBIOTICS FOR PETS MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
  • TABLE 225. ASIA-PACIFIC PROBIOTICS FOR PETS MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 226. ASIA-PACIFIC PROBIOTICS FOR PETS MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 227. ASIA-PACIFIC PROBIOTICS FOR PETS MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
  • TABLE 228. ASIA-PACIFIC PROBIOTICS FOR PETS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 229. ASIA-PACIFIC PROBIOTICS FOR PETS MARKET SIZE, BY BACTERIA, 2018-2032 (USD MILLION)
  • TABLE 230. ASIA-PACIFIC PROBIOTICS FOR PETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 231. ASIA-PACIFIC PROBIOTICS FOR PETS MARKET SIZE, BY MASS RETAIL, 2018-2032 (USD MILLION)
  • TABLE 232. ASIA-PACIFIC PROBIOTICS FOR PETS MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 233. ASIA-PACIFIC PROBIOTICS FOR PETS MARKET SIZE, BY PET SPECIALTY STORES, 2018-2032 (USD MILLION)
  • TABLE 234. ASIA-PACIFIC PROBIOTICS FOR PETS MARKET SIZE, BY PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 235. ASIA-PACIFIC PROBIOTICS FOR PETS MARKET SIZE, BY VETERINARY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 236. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 237. ASEAN PROBIOTICS FOR PETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 238. ASEAN PROBIOTICS FOR PETS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 239. ASEAN PROBIOTICS FOR PETS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 240. ASEAN PROBIOTICS FOR PETS MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
  • TABLE 241. ASEAN PROBIOTICS FOR PETS MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 242. ASEAN PROBIOTICS FOR PETS MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 243. ASEAN PROBIOTICS FOR PETS MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
  • TABLE 244. ASEAN PROBIOTICS FOR PETS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 245. ASEAN PROBIOTICS FOR PETS MARKET SIZE, BY BACTERIA, 2018-2032 (USD MILLION)
  • TABLE 246. ASEAN PROBIOTICS FOR PETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 247. ASEAN PROBIOTICS FOR PETS MARKET SIZE, BY MASS RETAIL, 2018-2032 (USD MILLION)
  • TABLE 248. ASEAN PROBIOTICS FOR PETS MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 249. ASEAN PROBIOTICS FOR PETS MARKET SIZE, BY PET SPECIALTY STORES, 2018-2032 (USD MILLION)
  • TABLE 250. ASEAN PROBIOTICS FOR PETS MARKET SIZE, BY PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 251. ASEAN PROBIOTICS FOR PETS MARKET SIZE, BY VETERINARY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 252. GCC PROBIOTICS FOR PETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 253. GCC PROBIOTICS FOR PETS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 254. GCC PROBIOTICS FOR PETS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 255. GCC PROBIOTICS FOR PETS MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
  • TABLE 256. GCC PROBIOTICS FOR PETS MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 257. GCC PROBIOTICS FOR PETS MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 258. GCC PROBIOTICS FOR PETS MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
  • TABLE 259. GCC PROBIOTICS FOR PETS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 260. GCC PROBIOTICS FOR PETS MARKET SIZE, BY BACTERIA, 2018-2032 (USD MILLION)
  • TABLE 261. GCC PROBIOTICS FOR PETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 262. GCC PROBIOTICS FOR PETS MARKET SIZE, BY MASS RETAIL, 2018-2032 (USD MILLION)
  • TABLE 263. GCC PROBIOTICS FOR PETS MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 264. GCC PROBIOTICS FOR PETS MARKET SIZE, BY PET SPECIALTY STORES, 2018-2032 (USD MILLION)
  • TABLE 265. GCC PROBIOTICS FOR PETS MARKET SIZE, BY PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 266. GCC PROBIOTICS FOR PETS MARKET SIZE, BY VETERINARY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 267. EUROPEAN UNION PROBIOTICS FOR PETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 268. EUROPEAN UNION PROBIOTICS FOR PETS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 269. EUROPEAN UNION PROBIOTICS FOR PETS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 270. EUROPEAN UNION PROBIOTICS FOR PETS MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
  • TABLE 271. EUROPEAN UNION PROBIOTICS FOR PETS MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 272. EUROPEAN UNION PROBIOTICS FOR PETS MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 273. EUROPEAN UNION PROBIOTICS FOR PETS MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
  • TABLE 274. EUROPEAN UNION PROBIOTICS FOR PETS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 275. EUROPEAN UNION PROBIOTICS FOR PETS MARKET SIZE, BY BACTERIA, 2018-2032 (USD MILLION)
  • TABLE 276. EUROPEAN UNION PROBIOTICS FOR PETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 277. EUROPEAN UNION PROBIOTICS FOR PETS MARKET SIZE, BY MASS RETAIL, 2018-2032 (USD MILLION)
  • TABLE 278. EUROPEAN UNION PROBIOTICS FOR PETS MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 279. EUROPEAN UNION PROBIOTICS FOR PETS MARKET SIZE, BY PET SPECIALTY STORES, 2018-2032 (USD MILLION)
  • TABLE 280. EUROPEAN UNION PROBIOTICS FOR PETS MARKET SIZE, BY PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 281. EUROPEAN UNION PROBIOTICS FOR PETS MARKET SIZE, BY VETERINARY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 282. BRICS PROBIOTICS FOR PETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 283. BRICS PROBIOTICS FOR PETS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 284. BRICS PROBIOTICS FOR PETS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 285. BRICS PROBIOTICS FOR PETS MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
  • TABLE 286. BRICS PROBIOTICS FOR PETS MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 287. BRICS PROBIOTICS FOR PETS MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 288. BRICS PROBIOTICS FOR PETS MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
  • TABLE 289. BRICS PROBIOTICS FOR PETS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 290. BRICS PROBIOTICS FOR PETS MARKET SIZE, BY BACTERIA, 2018-2032 (USD MILLION)
  • TABLE 291. BRICS PROBIOTICS FOR PETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 292. BRICS PROBIOTICS FOR PETS MARKET SIZE, BY MASS RETAIL, 2018-2032 (USD MILLION)
  • TABLE 293. BRICS PROBIOTICS FOR PETS MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 294. BRICS PROBIOTICS FOR PETS MARKET SIZE, BY PET SPECIALTY STORES, 2018-2032 (USD MILLION)
  • TABLE 295. BRICS PROBIOTICS FOR PETS MARKET SIZE, BY PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 296. BRICS PROBIOTICS FOR PETS MARKET SIZE, BY VETERINARY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 297. G7 PROBIOTICS FOR PETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 298. G7 PROBIOTICS FOR PETS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 299. G7 PROBIOTICS FOR PETS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 300. G7 PROBIOTICS FOR PETS MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
  • TABLE 301. G7 PROBIOTICS FOR PETS MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 302. G7 PROBIOTICS FOR PETS MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 303. G7 PROBIOTICS FOR PETS MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
  • TABLE 304. G7 PROBIOTICS FOR PETS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 305. G7 PROBIOTICS FOR PETS MARKET SIZE, BY BACTERIA, 2018-2032 (USD MILLION)
  • TABLE 306. G7 PROBIOTICS FOR PETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 307. G7 PROBIOTICS FOR PETS MARKET SIZE, BY MASS RETAIL, 2018-2032 (USD MILLION)
  • TABLE 308. G7 PROBIOTICS FOR PETS MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 309. G7 PROBIOTICS FOR PETS MARKET SIZE, BY PET SPECIALTY STORES, 2018-2032 (USD MILLION)
  • TABLE 310. G7 PROBIOTICS FOR PETS MARKET SIZE, BY PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 311. G7 PROBIOTICS FOR PETS MARKET SIZE, BY VETERINARY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 312. NATO PROBIOTICS FOR PETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 313. NATO PROBIOTICS FOR PETS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 314. NATO PROBIOTICS FOR PETS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 315. NATO PROBIOTICS FOR PETS MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
  • TABLE 316. NATO PROBIOTICS FOR PETS MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 317. NATO PROBIOTICS FOR PETS MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 318. NATO PROBIOTICS FOR PETS MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
  • TABLE 319. NATO PROBIOTICS FOR PETS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 320. NATO PROBIOTICS FOR PETS MARKET SIZE, BY BACTERIA, 2018-2032 (USD MILLION)
  • TABLE 321. NATO PROBIOTICS FOR PETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 322. NATO PROBIOTICS FOR PETS MARKET SIZE, BY MASS RETAIL, 2018-2032 (USD MILLION)
  • TABLE 323. NATO PROBIOTICS FOR PETS MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 324. NATO PROBIOTICS FOR PETS MARKET SIZE, BY PET SPECIALTY STORES, 2018-2032 (USD MILLION)
  • TABLE 325. NATO PROBIOTICS FOR PETS MARKET SIZE, BY PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 326. NATO PROBIOTICS FOR PETS MARKET SIZE, BY VETERINARY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 327. GLOBAL PROBIOTICS FOR PETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 328. UNITED STATES PROBIOTICS FOR PETS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 329. UNITED STATES PROBIOTICS FOR PETS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 330. UNITED STATES PROBIOTICS FOR PETS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 331. UNITED STATES PROBIOTICS FOR PETS MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
  • TABLE 332. UNITED STATES PROBIOTICS FOR PETS MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 333. UNITED STATES PROBIOTICS FOR PETS MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
  • TABLE 334. UNITED STATES PROBIOTICS FOR PETS MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
  • TABLE 335. UNITED STATES PROBIOTICS FOR PETS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 336. UNITED STATES PROBIOTICS FOR PETS MARKET SIZE, BY BACTERIA, 2018-2032 (USD MILLION)
  • TABLE 337. UNITED STATES PROBIOTICS FOR PETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 338. UNITED STATES PROBIOTICS FOR PETS MARKET SIZE, BY MASS RETAIL, 2018-2032 (USD MILLION)
  • TABLE 339. UNITED STATES PROBIOTICS FOR PETS MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 340. UNITED STATES PROBIOTICS FOR PETS MARKET SIZE, BY PET SPECIALTY STORES, 2018-2032 (USD MILLION)
  • TABLE 341. UNITED STATES PROBIOTICS FOR PETS MARKET SIZE, BY PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 342. UNITED STATES PROBIOTICS FOR PETS MARKET SIZE, BY VETERINARY CLINICS, 2018-2032 (USD M